Qulid refers to a project or company with several related items in the news cycle, including clinical programs like QRL-101 variant and QRL-201 variant from QurAlis, which are targeted therapies for Kv7 and STATHMIN-2. These programs are distinct from QuidelOrtho diagnostics (QDEL) or other similarly named entities. QurAlis has announced multiple clinical and licensing milestones for its Kv7.2/7.3 and STATHMIN-2 programs.
Sources
A high-level overview of ETRACS 2x Leveraged MSCI US Quality Factor TR ETN (QULL). Stay up to date on the latest price, chart, news, analysis, fundamentals, trading and investment tools.
seekingalpha.comQuidelOrtho (QDEL) news covers in vitro diagnostics, point-of-care molecular testing, LEX VELO, respiratory demand, earnings, guidance and governance. Latest QDEL news, June 2026.
www.stocktitan.netNews Archive - QurAlis
www.quralis.comView the latest news & press releases about QuidelOrtho Corporation - Common Stock (Nasdaq:QDEL)
markets.financialcontent.comQuidelOrtho Corp (QDEL) Latest News & Updates – Why is it moving? What’s happening today? Get real-time market sentiment and stock updates
public.comGet the market news, company earnings updates, stock data, and in-depth analysis for Quidel(QDEL) on Tiger Brokers' website.
www.itiger.comWhat's going on at Qilian International Holding Group (NASDAQ:QLI)? Read today's QLI news from trusted media outlets at MarketBeat.
www.marketbeat.comAnalyse Malaysia stock market better ever. Access everywhere. Available in Google Play Store and App Store!
www.klsescreener.com